Who is Cristcot?
Cristcot is a strategic pharmaceutical development and research company focused in the space of gastroenterology to address large gaps in disease management. The first product is intended for the treatment of ulcerative colitis of the rectum and has successfully completed the phase 3 clinical trial.
Design Philosophy: Unobtrusive Care
Unobtrusive Care is all about addressing THE PROBLEM WITHIN THE PROBLEM in order to improve the lives of patients and caregivers. We do this by removing the small, but critical obstacles that stand in the way of compliance and independence. Our solutions are most meaningful when the value we provide is unobtrusive, yet indispensable.
Pipeline
Cristcot’s development programs are built on patented drug formulations and delivery platforms designed for reliability, usability, and patient acceptance.
Lead Program: Treatment of Ulcerative Colitis of the Rectum
Cristcot’s lead investigational therapy has successfully completed phase 3 clinical evaluation for the treatment of acute flares in ulcerative colitis. The program has been developed to complement existing maintenance therapies to support the management of flare episodes.
Next-Generation Programs: Additional Products in Development and Evaluation
Our next-generation programs represent the future of disease management, with innovative products currently in development and evaluation to expand treatment options and improve patient outcomes.
Intellectual Property and Market Protections
Strong IP portfolio includes composition of matter and utility patents covering the drug formulation, devices, manufacturing processes, drug testing assay methods and trademarks, extending market exclusivity through late 2036.
Under the Hatch-Waxman Act and applicable FDA regulations, approval of a new drug application provides an exclusivity period that limits the approval pathway of competing generic applications.
Our Scientific Engagements
Cristcot regularly contributes to the gastroenterology and pharmaceutical delivery communities through scientific presentations, publications, and conference participation.
Selected recent presentations and publications: